Measuring Vascular Permeability In Vivo.
暂无分享,去创建一个
Dai Fukumura | Eelco F. J. Meijer | D. Fukumura | J. Baish | T. Padera | Timothy P Padera | James W Baish | Eelco F J Meijer
[1] R. Jain,et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.
[2] R K Jain,et al. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.
[3] R. Jain,et al. Strategies for advancing cancer nanomedicine. , 2013, Nature materials.
[4] Vladimir P Torchilin,et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.
[5] R K Jain,et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. , 2000, Cancer research.
[6] Dai Fukumura,et al. In vivo imaging of tumors. , 2010, Cold Spring Harbor protocols.
[7] Dai Fukumura,et al. Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.
[8] R. Jain,et al. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. , 1997, The American journal of pathology.
[9] Dai Fukumura,et al. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. , 2002, Cancer research.
[10] Dai Fukumura,et al. A nanoparticle size series for in vivo fluorescence imaging. , 2010, Angewandte Chemie.
[11] R K Jain,et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] Rakesh K. Jain,et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels , 2013, Nature Communications.
[13] R. Jain,et al. Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.
[14] R. Jain,et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.
[15] R. Jain,et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.
[16] R. Jain,et al. Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo. , 2013, Angewandte Chemie.
[17] R. Jain,et al. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. , 2013, Journal of the National Cancer Institute.
[18] Ricky T. Tong,et al. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. , 2006, Cancer research.
[19] Rakesh K. Jain,et al. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.
[20] R. Jain,et al. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] R K Jain,et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] Lei Xu,et al. Pancreas Microenvironment Promotes VEGF Expression and Tumor Growth: Novel Window Models for Pancreatic Tumor Angiogenesis and Microcirculation , 2001, Laboratory Investigation.
[24] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.
[25] R. Jain,et al. Angiopoietin-2 Interferes with Anti-VEGFR2–Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas , 2010, Clinical Cancer Research.
[26] M. Gassmann,et al. Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice , 2009, Proceedings of the National Academy of Sciences.
[27] J. Baish,et al. Angiopoietin‐4 increases permeability of blood vessels and promotes lymphatic dilation , 2015, The FASEB Journal.
[28] R. Jain,et al. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[30] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[31] G. Rosner,et al. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. , 1993, International journal of radiation oncology, biology, physics.
[32] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Carmeliet,et al. Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A 1 , 2001 .
[34] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[35] Lei Xu,et al. Perivascular nitric oxide gradients normalize tumor vasculature , 2008, Nature Medicine.
[36] R. Jain,et al. Perfusion of Single Tumor Microvessels: Application to Vascular Permeability Measurement , 1996, Microcirculation.
[37] Lei Xu,et al. Tumour biology: Herceptin acts as an anti-angiogenic cocktail , 2002, Nature.
[38] P. Carmeliet,et al. Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma , 2013, Cell.
[39] Ou Chen,et al. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. , 2011, Angewandte Chemie.
[40] R K Jain,et al. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.
[41] R. Jain,et al. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.
[42] Lei Xu,et al. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. , 2006, Cancer research.
[43] Dai Fukumura,et al. Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.
[44] Dai Fukumura,et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. , 2008, Blood.
[45] W. Denk,et al. Two-photon laser scanning fluorescence microscopy. , 1990, Science.
[46] R K Jain,et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.